2020年药品定价更新、策略及趋势报告 - Scrip（英文版）（15页）.pdf

1、Drug pricing update: strategies and trends 2 / May 2020 Informa UK Ltd 2020 (Unauthorized photocopying prohibited.) Executive Summary Global spending on medicines will continue to increase through 2024, but at a lower rate than the previous five years due to the impact of discounts, rebates and pate

2、nt expirations. Global spending on prescription drugs hasnt been expected to take a major downturn, but the IQVIA Institute for Human Data Science said the growth rate is likely to decelerate over the next five years due to factors such as discounting and rebates, generic/biosimilar erosion and pres

3、sures created by the continued high volume of new drugs reaching the market. In the Global Use of Medicine Spending and Usage Trends: Outlook to 2024 report issued on 17 March, the institute projects that global medicine spending will increase by 2%-5% from this year through 2024 on a net basis, lik

4、ely down from the annualized increase of 4.2% over the previous decade. Releasing this report in the midst of the COVID-19 outbreak, however, IQVIA had to couch its estimates to account for current volatility in health care and financial markets. (Also see “Coronavirus Update: Drug Launches Could Be

5、 Hit, New Twist In CureVac Controversy, Moderna Doses First Patient” - Scrip, 17 Mar, 2020.) The projections included in the report were made before the COVID-19 outbreak was termed a pandemic and do not explicitly factor in any impact. “The overall impact on medicine spending and use to date is tho

6、ught to be very small, though this may change depending on the length and severity of disruption to communities and health systems,” IQVIA said in a same-day statement. The institute has not seen any significant impact on medicine volume consumption domestically or globally, so far, but a longer dis